Markets
1 views
Molbio Diagnostics share price hits 20% upper circuit, jumps 87% from IPO price
Molbio Diagnostics shares surged 20% on September 10, 2026, reaching an all-time high of ₹1,509.70. The company reported a profit of ₹52.74 crore for Q1 FY27 and a sharp increase in Truenat test-kit volumes, reinforcing its strong market…

Mint Verified Source
Reported by Dhanya Nagasundaram · Syndicated via official news feed
Explore all Markets stories
Syndicated feed content with full publisher credit.
Markets Desk
More in Markets
Continue reading verified coverage and related developments on this desk.